Current - voltage characteristics of break junctions of high-TcT_c superconductors

The current-voltage ($I$-$V$) characteristics of break junctions of polycrystalline La$_{1.85}$Sr$_{0.15}$CuO$_4$, Y$_{0.75}$Lu$_{0.25}$Ba$_2$Cu$_3$O$_{7-\delta}$, Bi$_{1.8}$Pb$_{0.3}$Sr$_{1.9}$Ca$_2$Cu$_3$O$_x$ and composite YBa$_2$Cu$_3$O$_{7-\delta}$ + Ag are investigated. The experimental $I$-$V$ curves exhibit the specific peculiarities of superconductor/normal-metal/superconductor junctions. The relation between an $I$-$V$ characteristic of network of weak links and $I$-$V$ dependencies of typical weak links is suggested to describe the experimental data. The $I$-$V$ curves of typical weak links are calculated by the K\"{u}mmel - Gunsenheimer - Nicolsky model considering the multiple Andreev reflections.Comment: 9 pages, 5 figures, 2 Table

Traité scientifique et industriel des plantes textiles

Conté: 2. La ramie : culture et décorticage. 3. La ramie : dégommage et travail industrie

Current-voltage characteristics of quasi-one-dimensional superconductors: An S-curve in the constant voltage regime

Applying a constant voltage to superconducting nanowires we find that its IV-characteristic exhibits an unusual S-behavior. This behavior is the direct consequence of the dynamics of the superconducting condensate and of the existence of two different critical currents: j_{c2} at which the pure superconducting state becomes unstable and j_{c1}<j_{c2} at which the phase slip state is realized in the system.Comment: 4 pages, 5 figures, replaced with minor change

Experimental and Clinical Use of Therapeutic Hypothermia for Ischemic Stroke: Opportunities and Limitations

Stroke remains a disease with a serious impact on quality of life but few effective treatments exist. There is an urgent need to develop and/or improve neuroprotective strategies to combat this. Many drugs proven to be neuroprotective in experimental models fail to improve patient outcome in a clinical setting. An emerging treatment, therapeutic hypothermia (TH), is a promising neuroprotective therapy in stroke management. Several studies with TH in experimental models and small clinical trials have shown beneficial effects. Despite this, implementation into the clinical setting is still lacking due to methodological considerations as well as hypothermia-related complications. This paper discusses the possible opportunities and limitations of the use of TH in animal models and the translation into the clinic

The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia

Neuroinflammation is a key element in the ischemic cascade after cerebral ischemia that results in cell damage and death in the subacute phase. However, anti-inflammatory drugs do not improve outcome in clinical settings suggesting that the neuroinflammatory response after an ischemic stroke is not entirely detrimental. This review describes the different key players in neuroinflammation and their possible detrimental and protective effects in stroke. Because of its inhibitory influence on several pathways of the ischemic cascade, hypothermia has been introduced as a promising neuroprotective strategy. This review also discusses the influence of hypothermia on the neuroinflammatory response. We conclude that hypothermia exerts both stimulating and inhibiting effects on different aspects of neuroinflammation and hypothesize that these effects are key to neuroprotection